What is SN-38 Glucuronide?

SN-38 Glucuronide is a metabolite of the chemotherapy drug irinotecan. It is formed in the body when irinotecan is broken down by enzymes.

How does SN-38 Glucuronide work in the body?

SN-38 Glucuronide works by disrupting the DNA in cancer cells, leading to cell death. This helps to slow down the growth and spread of cancer.

What are the potential benefits of using SN-38 Glucuronide?

Some potential benefits of using SN-38 Glucuronide include improved treatment outcomes for cancer patients, reduced side effects compared to other chemotherapy drugs, and the ability to target specific types of cancer cells.

Are there any side effects associated with SN-38 Glucuronide?

Like any medication, SN-38 Glucuronide may cause side effects. Some common side effects may include nausea, vomiting, diarrhea, fatigue, and a decreased white blood cell count. It is important to discuss any potential side effects with your healthcare provider.

How is SN-38 Glucuronide administered to patients?

SN-38 Glucuronide is typically administered intravenously by a healthcare provider in a clinical setting. The dosage and frequency of administration will vary depending on the specific type of cancer being treated and the patient's individual health status.